Prognosis means the likely course of a health condition, based on medical experience.
It is very difficult to predict the course of multiple sclerosis. The type, duration, severity and impact of symptoms will vary from individual to individual. Some people will go for long periods with few or no symptoms whilst others will experience more frequent or persistent problems.
There are some factors that have been shown to suggest how MS may develop. These have been observed in long-term studies and reflect a general trend. They do not represent a guide to how a specific person's MS will develop. Multiple sclerosis remains a very unpredictable condition.
Factors that are associated with a relatively better disease course are:
What can I do to improve my prognosis?
There is no direct evidence to link dietary interventions or supplements to improved prognosis in MS. However, it is possible to reduce your risk of co-morbidities through healthy living. For example, there is a link between a Mediterranean type diet and reduced vascular disease. Vascular disease co-morbidities are associated with increasing disability in MS, and can lead to lowered life expectancy and increased EDSS (disability) score.
Would knowing your prognosis be helpful?
Research suggests that people with MS have mixed feelings about knowing their likely disease course. For some people with MS, they aim to live in the moment and try not to worry about what the future might hold, so they avoid finding out too much about later stage MS. However, for other people with MS, knowing their prognosis could reduce their anxiety from not knowing what's likely to happen, and enable them to make plans.
Before the current era of effective disease-modifying drugs (DMDs), the only treatment would have been to alleviate MS symptoms, and knowing your prognosis would not change any of that treatment. However today, having a clear idea of the disease pathway you are likely to be on might shape your decisions about what kind of DMD is appropriate for you. You might be more likely to opt for the highly effective and higher risk DMD options if the evidence suggested that you would be likely to experience a worse disease course. If you knew the likelihood was that you were not going to experience extreme symptoms or disability, then you might stick to low-risk but lower efficacy treatments.
Much research effort is currently aimed at answering this question, looking at factors like brain volume and optic nerve size in an attempt to find markers that might be linked to better or worse disease pathways. It is still early days, but the aim is to help people understand their likely prognosis and make it easier for them to choose the right treatment.
Last reviewed: August 2014
This page will be reviewed within three years
- Handb Clin Neurol. 2014;122:371-91 Summary Early prognosis of multiple sclerosis.
- Current Opinion in Neurology 2007;20(3):269-274. Summary Natural history of multiple sclerosis: risk factors and prognostic indicators.
- PLoS One. 2018; 13(2): e0193407. Full article Do people with multiple sclerosis want to know their prognosis? A UK nationwide study